Valion Bio VBIO
NASDAQ VBIO
$0.54 +0.02 (+3.85%)
At close: Nov 13, 2026 · 4:00 PM EST

Valion Bio (VBIO) Other Non-Current Liabilities (2020 - 2026)

Updated

Valion Bio (VBIO) reported Other Non-Current Liabilities of $454,000 for Q2 2026.

Analysis

Valion Bio (VBIO) Other Non-Current Liabilities (2020 - 2026) Analysis & Trends

At the end of FY2025, Valion Bio posted Other Non-Current Liabilities of $292,000.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn
5 Novartis Ag 306.35 Bn 279.93 Bn -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn
10 Valion Bio 73,008.00 -25.39 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 666,000.00
Mar 31, 2026 510,000.00
Dec 31, 2025 340,000.00
Dec 31, 2020 717,000.00
API Access

Valion Bio Other Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=VBIO&period=max&api_key=YOUR_API_KEY